Settlement Reached In Patent Dispute Over Enzyme Blends
The companies had been doing battle in a Maryland federal court as well as the U.S. Trademark and Patent office.
La Jolla, California-based Stratagene Corp. and Takara Bio—which is headquartered in Shiga, Japan—nipped potential future conflicts in the bud by putting in place a cross-licensing deal for the patents in question. The only payments involved...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login